Optimum Investment Advisors trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 3.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,789 shares of the healthcare conglomerate’s stock after selling 320 shares during the quarter. UnitedHealth Group comprises 1.7% of Optimum Investment Advisors’ portfolio, making the stock its 10th largest position. Optimum Investment Advisors’ holdings in UnitedHealth Group were worth $3,940,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently added to or reduced their stakes in UNH. Wallace Capital Management Inc. raised its holdings in shares of UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after buying an additional 19 shares during the last quarter. Western Pacific Wealth Management LP boosted its position in UnitedHealth Group by 2.2% during the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after acquiring an additional 19 shares during the period. MCF Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after purchasing an additional 20 shares during the period. Axiom Financial Strategies LLC lifted its holdings in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock worth $291,000 after purchasing an additional 20 shares during the period. Finally, 44 Wealth Management LLC raised its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock worth $662,000 after buying an additional 21 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
UnitedHealth Group Trading Up 1.3 %
NYSE:UNH opened at $517.72 on Friday. The stock has a market cap of $473.57 billion, a PE ratio of 33.40, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock’s 50-day moving average is $510.19 and its two-hundred day moving average is $547.11. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.
Analyst Upgrades and Downgrades
UNH has been the topic of a number of research analyst reports. Barclays lowered their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company cut their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.
Check Out Our Latest Report on UnitedHealth Group
Insider Activity at UnitedHealth Group
In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- 3 Fintech Stocks With Good 2021 Prospects
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- The 3 Best Retail Stocks to Shop for in August
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.